Your wife has chronic / relapsing ITP (Immune Thrombocytopenia) — a pattern of episodes since childhood, with spontaneous remissions in between, and now a more significant drop (to 30–40,000) with heavy menstrual bleeding contributing to anemia/blood loss.
The excellent response (platelets jumped to 460,000 in just 7–8 days) on Wysolone (prednisolone) + Eltrombopag is very encouraging — this is a very good response to second-line therapy (TPO-RA = thrombopoietin receptor agonist).
Should you continue Eltrombopag?
→ Yes, continue it for now — do not stop abruptly on your own.
Why continue?
• Stopping too early (especially when platelets are still climbing or just reached normal) often causes rapid relapse in ITP (platelets can drop again within days to weeks).
• Eltrombopag helps keep platelets stable while the immune system is being calmed by steroids (and hopefully enters a longer remission).
• Current level (460,000) is actually a bit high — this is common early on with TPO-RAs (over-response), but it is not dangerous in ITP patients.
Does continuing Eltrombopag increase risk of blood clots?
→ The risk is very low in ITP patients.
• Real-world data and studies show thrombotic events (clots) occur in only ~2–6% of patients on eltrombopag (romiplostim similar), and most happen in people who already have major clot risk factors (atrial fibrillation, previous clots, cancer, very high platelets >1 million for long time, immobility).
• At 460,000, the risk is not significantly increased compared to normal people.
• Doctors usually reduce/stop the dose when platelets stay consistently >150–200–300 ×10⁹/L for several weeks.
Next Steps
• Do NOT stop Eltrombopag yourself — sudden stop can cause rebound drop in platelets (sometimes very severe).
• Contact her hematologist as soon as possible (within 1–2 weeks or sooner if platelets keep rising above 600–800k):
• Ask for a dose reduction plan (e.g., reduce eltrombopag from current dose to half or every other day) while monitoring platelets 1–2 times per week.
• Typical goal: keep platelets 50–150 ×10⁹/L (safe range — no bleeding risk, no excessive clot risk).
• Discuss steroid tapering — Wysolone should be reduced slowly (e.g., 5–10 mg every 1–2 weeks) to lowest effective dose or off completely if platelets stay stable on eltrombopag alone.
• Repeat CBC (platelet count) every 3–7 days until stable, then every 2–4 weeks.
Health Tips
• Watch for any signs of clotting (sudden leg swelling/pain, chest pain, shortness of breath, severe headache) — rare, but report immediately.
• Avoid injury / trauma while platelets are high (normal precautions).
• Continue iron + folic acid if she is anemic from heavy bleeding.
• Heavy periods: discuss tranexamic acid or hormonal options (e.g., progesterone) with gynecologist to reduce bleeding during future low-platelet episodes.
• Most patients with good response to TPO-RAs like eltrombopag can eventually reduce or stop it after 6–24 months if remission is sustained — but it is individualized.
This is a very favorable response — she is in a strong position now.
The key is gradual, doctor-guided tapering of both steroids and eltrombopag while keeping platelets in a safe range.
Please consult her hematologist soon to make the exact plan — do not adjust doses on your own.
For more help (share latest platelet count or doctor’s current dose), feel free to ask.
Wishing her continued good response and long remission